Hereditary gingival fibromatosis: Characteristics and novel putative pathogenic mechanisms

Journal of Dental Research

Volumn 86, Issue 1, 2007, Pages 25-34

  Hakkinen L ^a   Csiszar, A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Gingiva; Hereditary; Overgrowth; Pathogenesis; SOS 1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SOS PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CELL PROLIFERATION; FIBROBLAST; GENETIC HETEROGENEITY; GENETICS; GINGIVA FIBROMATOSIS; HUMAN; MUTATION; PATHOLOGY; REVIEW;

CELL PROLIFERATION; FIBROBLASTS; FIBROMATOSIS, GINGIVAL; GENETIC HETEROGENEITY; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SOS1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846590980     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600104     Document Type: Review

References (143)

1. Agell N, Bachs O, Rocamora N, Villalonga P (2002). Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell Signal 14:649-654.
2. Ala-aho R, Kähäri VM (2005). Collagenases in cancer. Biochimie 87:273-286.
3. Alimohamad H, Habijanac T, Larjava H, Häkkinen L (2005). Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva. J Periodontal Res 40:73-86.
4. Almeida JP, Coletta RD, Silva SD, Agostini M, Vargas PA, Bozzo L, et al. (2005). Proliferation of fibroblasts cultured from normal gingiva and hereditary gingival fibromatosis is dependent on fatty acid synthase activity. J Periodontol 76:272-278.
5. Anderson J, Cunliffe WJ, Roberts DF, Close H (1969). Hereditary gingival fibromatosis. Br Med 73:218-219.
6. Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, et al. (2005). Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37:1038-1040.
7. Araiche M, Brode H (1959). A case of fibromatosis gingivae. Oral Surg Oral Med Oral Pathol 12:1307-1310.
8. Araujo CS, Graner E, Almeida OP, Sauk JJ, Coletta RD (2003). Histomorphometric characteristics and expression of epidermal growth factor and its receptor by epithelial cells of normal gingiva and hereditary gingival fibromatosis. J Periodontal Res 38:237-241.
9. Baptista IP (2002). Hereditary gingival fibromatosis: a case report. J Clin Periodontol 29:871-874.
10. Beer HD, Gassmann MG, Munz B, Steiling H, Engelhardt F, Bleuel K, et al. (2000). Expression and function of keratinocyte growth factor and activin in skin morphogenesis and cutaneous wound repair. J Invest Dermatol Symp Proc 5:34-39.
11. Behrendt N (2004). The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling. Biol Chem 385:103-136.
12. Bekisz O, Darimont F, Rompen EH (2000). Diffuse but unilateral gingival enlargement associated with von Recklinghausen neurofibromatosis: a case report. J Clin Periodontol 27:361-365.
13. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA, et al. (2001). Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 114:2755-2773.
14. Benbow U, Brinckerhoff CE (1997). The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15:519-526.
15. Bentires-Alj M, Kontaridis MI, Neel BG (2006). Stops along the RAS pathway in human genetic disease. Nat Med 12:283-285.
16. Berchtold MW, Egli R, Rhyner JA, Hameister H, Strehler EE (1993). Localization of the human bona fide calmodulin genes CALM1, CALM2, and CALM3 to chromosomes 14q24-q31, 2p21.1-p21.3, and 19q13.2-q13.3. Genomics 16:461-465.
17. Bhide VM, Laschinger CA, Arora PD, Lee W, Häkkinen L, Larjava H, et al. (2005). Collagen phagocytosis by fibroblasts is regulated by decorin. J Biol Chem 280:23103-23113.
18. Bhowmick SK, Gidvani VK, Rettig KR (2001). Hereditary gingival fibromatosis and growth retardation. Endocr Pract 7:383-387.
19. Blom IE, Goldschmeding R, Leask A (2002). Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21:473-482.
20. Casavecchia P, Uzel MI, Kantarci A, Hasturk H, Dibart S, Hart TC, et al (2004). Hereditary gingival fibromatosis associated with generalized aggressive periodontitis: a case report. J Periodontol 75:770-778.
21. Chardin P, Mattei MG (1994). Chromosomal localization of two genes encoding human ras exchange factors: SOS1 maps to the 2p22→p16 region and SOS2 to the 14q21→q22 region of the human genome. Cytogenet Cell Genet 66:68-69.
22. Chavrier C, Couble ML (1979). Ultrastructure of the connective corium in hereditary gingival hyperplasia. J Biol Buccale 7:191-203.
23. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A (2002). CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 62:1149-1159.
24. Coletta RD, Almeida OP, Graner E, Page RC, Bozzo L (1998). Differential proliferation of fibroblasts cultured from hereditary gingival fibromatosis and normal gingiva. J Periodontal Res 33:469-475.
25. Coletta RD, Almeida OP, Reynolds MA, Sauk JJ (1999). Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-beta 1 autocrine stimulation. J Periodontal Res 34:457-463.
26. Conkright MD, Montminy M (2005). CREB: the unindicted cancer co-conspirator. Trends Cell Biol 15:457-459.
27. Corbalan-Garcia S, Yang SS, Degenhardt KR, Bar-Sagi D (1996). Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol 16:5674-5682.
28. Cullen PJ, Lockyer PJ (2002). Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol 3:339-348.
29. Cussac D, Frech M, Chardin P (1994). Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline-rich motifs. EMBO J 13:4011-4021.
30. Daly AK, Cholerton S, Gregory W, Idle JR (1993). Metabolic polymorphisms. Pharmacol Ther 57:129-160.
31. de Andrade CR, Cotrin P, Graner E, Almeida OP, Sauk JJ, Coletta RD (2001). Transforming growth factor-beta 1 autocrine stimulation regulates fibroblast proliferation in hereditary gingival fibromatosis. J Periodontol 72:1726-1733.
32. Doufexi A, Mina M, Ioannidou E (2005). Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review. J Periodontol 76:3-10.
33. Duncan MR, Berman B (1987). Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons. J Clin Invest 79:1318-1324.
34. East L, Isacke CM (2002). The mannose receptor family. Biochim Biophys Acta 1572:364-386.
35. Farrer-Brown G, Lucas RB, Winstock D (1972). Familial gingival fibromatosis: an unusual pathology. J Oral Pathol 1:76-83.
36. Flaitz CM, Coleman GC (1995). Differential diagnosis of oral enlargements in children. Pediatr Dent 17:294-300.
37. Fletcher JP (1966). Gingival abnormalities of genetic origin: a preliminary communication with special reference to hereditary generalized gingival fibromatosis. J Dent Res 45:597-612.
38. Fryns JP (1996). Gingival fibromatosis and partial duplication of the short arm of chromosome 2 (dup(2)(p13→p21)). Ann Genet 39:54-55.
39. Ghosh AK, Yuan W, Mori Y, Varga J (2000). Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 19:3546-3555.
40. Gorlin R, Cohen MM, Levis LS (1990). Syndromes of the head and neck. 3rd ed. New York: Oxford University Press.
41. Govinden R, Bhoola KD (2003). Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 98:257-265.
42. Gunhan O, Gardner DG, Bostanci H, Gunhan M (1995). Familial gingival fibromatosis with unusual histologic findings. J Periodontol 66:1008-1011.
43. Häkkinen L, Larjava H (1992). Characterization of fibroblast clones from periodontal granulation tissue in vitro. J Dent Res 71:1901-1907.
44. Häkkinen L, Oksala O, Salo T, Rahemtulla F, Larjava H (1993). Immunohistochemical localization of proteoglycans in human periodontium. J Histochem Cytochem 41:1689-1699.
45. Häkkinen L, Uitto VJ, Larjava H (2000). Cell biology of gingival wound healing. Periodontol 2000 24:127-152.
46. Häkkinen L, Koivisto L, Gardner H, Saarialho-Kere U, Carroll JM, Lakso M, et al. (2004). Increased expression of beta6-integrin in skin leads to spontaneous development of chronic wounds. Am J Pathol 164:229-242.
47. Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, Edwards DR, et al. (2003). The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta I. J Biol Chem 278:10304-10313.
48. Hanks S, Adams S, Douglas J, Arbour L, Atherton DJ, Balci S, et al. (2003). Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 73:791-800.
49. Harris RC, Chung E, Coffey RJ (2003). EGF receptor ligands. Exp Cell Res 284:2-13.
50. Hart TC, Pallos D, Bowden DW, Bolyard J, Pettenati MJ, Cortelli JR (1998). Genetic linkage of hereditary gingival fibromatosis to chromosome 2p21. Am J Hum Genet 62:876-883.
51. Hart TC, Pallos D, Bozzo L, Almeida OP, Marazita ML, O'Connell JR, et al. (2000). Evidence of genetic heterogeneity for hereditary gingival fibromatosis. J Dent Res 79:1758-1764.
52. Hart TC, Zhang Y, Gorry MC, Hart PS, Cooper M, Marazita ML, et al. (2002). A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1. Am J Hum Genet 70:943-954.
53. Hashimoto K (2000). Regulation of keratinocyte function by growth factors. J Dermatol Sci 24(Suppl 1):S46-S50.
54. Hassell TM (1993). Tissues and cells of the periodontium. Periodontol 2000 3:9-38.
55. Hassell TM, Page RC, Narayanan AS, Cooper CG (1976). Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. Proc Natl Acad Sci USA 73:2909-2912.
56. Hennekam RC (2003). Costello syndrome: an overview. Am J Med Genet C Semin Med Genet 117:42-48.
57. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, et al. (1994). Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302:527-534.
58. Honardoust H, Jiang G, Koivisto L, Wienke D, Isacke C, Larjava H, et al. (2006). Expression of Endo180 is spatially and temporally regulated during wound healing. Histopathology 49:634-648.
59. Hong HH, Uzel MI, Duan C, Sheff MC, Trackman PC (1999). Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest 79:1655-1667.
60. Horning GM, Fisher JG, Barker BF, Killoy WJ, Lowe JW (1985). Gingival fibromatosis with hypertrichosis. A case report. J Periodontol 56:344-347.
61. Impey S, Fong AL, Wang Y, Cardinaux JR, Fass DM, Obrietan K, et al. (2002). Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34:235-244.
62. Innocenti M, Tenca P, Frittoli E, Faretta M, Tocchetti A, Di Fiore PP, et al (2002). Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol 156:125-136.
63. Iwamoto T (2004). Forefront of Na+/Ca2+ exchanger studies: molecular pharmacology of Na+/Ca2+ exchange inhibitors. J Pharmacol Sci 96:27-32.
64. Janknecht R, Nordheim A (1996). MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem Biophys Res Commun 228:831-837.
65. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW (2003). Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31-53.
66. Kahl CR, Means AR (2003). Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24:719-736.
67. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, et al. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
68. Kasaboglu O, Turner C, Balci S (2004). Hereditary gingival fibromatosis and sensorineural hearing loss in a 42-year-old man with Jones syndrome. Genet Couns 15:213-218.
69. Kataoka M, Kido J, Shinohara Y, Nagata T (2005). Drug-induced gingival overgrowth-a review. Biol Pharm Bull 28:1817-1821.
70. Kelekis-Cholakis A, Wiltshire WA, Birek C (2002). Treatment and long-term follow-up of a patient with hereditary gingival fibromatosis: a case report. J Can Dent Assoc 68:290-294.
71. Kerr B, Delrue MA, Sigaudy S, Perveen R, Marche M, Burgelin I, et al. (2006). Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 43:401-405.
72. Kondoh T, Kamimura N, Tsuru A, Matsumoto T, Matsuzaka T, Moriuchi H (2001). A case of Schinzel-Giedion syndrome complicated with progressive severe gingival hyperplasia and progressive brain atrophy. Pediatr Int 43:181-184.
73. Larjava H, Häkkinen L, Rahemtulla F (1992). A biochemical analysis of human periodontal tissue proteoglycans. Biochem J 284:267-274.
74. Leask A, Holmes A, Black CM, Abraham DJ (2003). Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278:13008-13015.
75. Leivonen SK, Chantry A, Häkkinen L, Han J, Kähäri VM (2002). Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. J Biol Chem 277:46338-46346.
76. Leivonen SK, Häkkinen L, Liu D, Kähäri VM (2005). Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts. J Invest Dermatol 124:1162-1169.
77. J, Zhang YP, Kirsner RS (2003). Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 60:107-114.
78. N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, et al. (1993). Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363:85-88.
79. Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, et al. (1995). Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 25:9-18.
80. Lynch M, Brightman VJ, Greenberg MS (1994). Burket's oral medicine: diagnosis and treatment. 9th ed. Philadelphia: J.B. Lippincott.
81. Macias-Flores MA, Garcia-Cruz D, Rivera H, Escobar-Lujan M, Melendrez-Vega A, Rivas-Campos D, et al. (1984). A new form of hypertrichosis inherited as an X-linked dominant trait. Hum Genet 66:66-70.
82. Marshall RI, Bartold PM (1999). A clinical review of drug-induced gingival overgrowths. Aust Dent J 44:219-232.
83. Martelli-Junior H, Cotrim P, Graner E, Sauk JJ, Coletta RD (2003). Effect of transforming growth factor-beta 1, interleukin-6, and interferon-gamma on the expression of type I collagen, heat shock protein 47, matrix metalloproteinase (MMP)-1 and MMP-2 by fibroblasts from normal gingiva and hereditary gingival fibromatosis. J Periodontol 74:296-306.
84. Martelli-Junior H, Lemos DP, Silva CO, Graner E, Coletta RD (2005). Hereditary gingival fibromatosis: report of a five-generation family using cellular proliferation analysis. J Periodontol 76:2299-2305.
85. Matheson S, Larjava H, Häkkinen L (2005). Distinctive localization and function for lumican, fibromodulin and decorin to regulate collagen fibril organization in periodontal tissues. J Periodontal Res 40:312-324.
86. McCulloch CA (2004). Drug-induced fibrosis: interference with the intracellular collagen degradation pathway. Curr Opin Drug Discov Devel 7:720-724.
87. McCulloch CA, Knowles GC (1993). Deficiencies in collagen phagocytosis by human fibroblasts in vitro: a mechanism for fibrosis? J Cell Physiol 155:461-471.
88. Mettouchi A, Klein S, Guo W, Lopez-Lago M, Lemichez E, Westwick JK, et al. (2001). Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol Cell 8:115-127.
89. Midwood KS, Williams LV, Schwarzbauer JE (2004). Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 36:1031-1037.
90. Morey MA, Higgins RR (1990). Ectro-amelia syndrome associated with an interstitial deletion of 7q. Am J Med Genet 35:95-99.
91. Mulder KM (2000). Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11:23-35.
92. Mulsow JJ, Watson RW, Fitzpatrick JM, O'Connell PR (2005). Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg 242:880-887.
93. Munaron L (2002). Calcium signalling and control of cell proliferation by tyrosine kinase receptors. Int J Mol Med 10:671-676.
94. Nimnual A, Bar-Sagi D (2002). The two hats of SOS. Sci STKE 145:PE36.
95. Nimnual AS, Yatsula BA, Bar-Sagi D (1998). Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 279:560-563.
96. Nunes I, Munger J, Harpel JG, Nagano Y, Shapiro R, Gleizes PE, et al. (1998). Structure and activation of the large latent transforming growth factor-Beta complex. J Am Optom Assoc 69:643-648.
97. Ohnishi H, Miyata T, Yasuda H, Satoh Y, Hanatsuka K, Kita H, et al. (2004). Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta 1 regulation of pancreatic stellate cellular functions. J Biol Chem 279:8873-8878.
98. Pallos D, Hart TC, Cortelli JR, Yamauchi M (1997). Altered post-translational modification of collagen in hereditary gingival fibromatosis (abstract). J Dent Res 76:32.
99. Qian X, Esteban L, Vass WC, Upadhyaya C, Papageorge AG, Yienger K., et al. (2000). The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. EMBO J 19:642-654.
100. Raeste AM, Collan Y, Kalpinen E (1978). Hereditary fibrous hyperplasia of the gingiva with varying penetrance and expressivity. Scand J Dent Res 86:357-365.
101. Ramon Y, Berman W, Bubis JJ (1967). Gingival fibromatosis combined with cherubism. Oral Surg Oral Med Oral Pathol 24:435-448.
102. Ravanti L, Heino J, Lopez-Otin C, Kähäri VM (1999a). Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 274:2446-2455.
103. Ravanti L, Häkkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J, et al. (1999b). Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 274:37292-37300.
104. Redman RS, Ward CC, Patterson RH (1985). Focus of epithelial dysplasia arising in hereditary gingival fibromatosis. J Periodontol 56:158-162.
105. Rivera H, Ramirez-Duenas ML, Figuera LE, Gonzalez-Montes RM, Vasquez AI (1992). Opposite imbalances of distal 14q in two unrelated patients. Ann Genet 35:97-100.
106. Sakamoto R, Nitta T, Kamikawa Y, Kono S, Kamikawa Y, Sugihara K, et al. (2002). Histochemical, immunohistochemical, and ultrastructural studies of gingival fibromatosis: a case report. Med Electron Microsc 35:248-254.
107. Sardella A, Carrassi A, Caputo R, Monti M, Gotte P (1998). Gingival lesions in a patient with dermochondrocorneal dystrophy (Francois syndrome). A case report. J Clin Periodontol 25:1047-1049.
108. Scarano A, Artese L, Annibali S, Piccolomini M, Piattelli A (2005). Bilateral diffuse gingival enlargement in a patient with type 1 neurofibromatosis. J Otolaryngol 34:282-285.
109. Scherer A, Graff JM (2000). Calmodulin differentially modulates Smad1 and Smad2 signaling. J Biol Chem 275:41430-41438.
110. Schiller M, Javelaud D, Mauviel A (2004). TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 35:83-92.
111. Scita G, Nordstrom J, Carbone R, Tenca P, Giardina G, Gutkind S, et al. (1999). EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401:290-293.
112. Sciubba JJ, Niebloom T (1986). Juvenile hyaline fibromatosis (Murray-Puretic-Drescher syndrome): oral and systemic findings in siblings. Oral Surg Oral Med Oral Pathol 62:397-409.
113. Secombe J, Pierce SB, Eisenman RN (2004). Myc: a weapon of mass destruction. Cell 117:153-156.
114. Seymour RA, Thomason JM, Ellis JS (1996). The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 23(3 Pt 1):165-175.
115. Shafer WG (1983). A textbook of oral pathology. 4th ed. Philadelphia: W.B. Saunders.
116. Shapiro P (2002). Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy. Crit Rev Clin Lab Sci 39:285-330.
117. Shashi V, Pallos D, Pettenati MJ, Cortelli JR, Fryns JP, von Kap-Herr C, et al. (1999). Genetic heterogeneity of gingival fibromatosis on chromosome 2p. J Med Genet 36:683-686.
118. Sheppard D (2005). Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 24:395-402.
119. Shieh BH, Xia Y, Sparkes RS, Klisak I, Lusis AJ, Nicoll DA, et al. (1992). Mapping of the gene for the cardiac sarcolemmal Na(+)-Ca2+ exchanger to human chromosome 2p21-p23. Genomics 12:616-617.
120. Shirasuna K, Okura M, Watatani K, Hayashido Y, Saka M, Matsuya T (1988). Abnormal cellular property of fibroblasts from congenital gingival fibromatosis. J Oral Pathol 17:381-385.
121. Sibilia M, Fleischmann A, Behrens A, Stingl L, Carroll J, Watt FM, et al. (2000). The EOF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102:211-220.
122. Sini P, Cannas A, Koleske AJ, Di Fiore PP, Scita G (2004). Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation. Nat Cell Biol 6:268-274.
123. Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J (2004). Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell 119:393-405.
124. Steffensen B, Häkkinen L, Larjava H (2001). Proteolytic events of wound-healing-coordinated interactions among matrix metalloproteinases (MMPs), integrals, and extracellular matrix molecules. Crit Rev Oral Biol Med 12:373-398.
125. Stull JT (2001). Ca2+-dependent cell signaling through calmodulin-activated protein phosphatase and protein kinases [minireview series]. J Biol Chem 276:2311-2312.
126. Tipton DA, Dabbous MK (1998). Autocrine transforming growth factor beta stimulation of extracellular matrix production by fibroblasts from fibrotic human gingiva. J Periodontol 69:609-619.
127. Tipton DA, Howell KJ, Dabbous MK (1997). Increased proliferation, collagen, and fibronectin production by hereditary gingival fibromatosis fibroblasts. J Periodontol 68:524-530.
128. Tipton DA, Woodard III ES, Baber MA, Dabbous M (2004). Role of the c-myc proto-oncogene in the proliferation of hereditary gingival fibromatosis fibroblasts. J Periodontol 75:360-369.
129. Trackman PC, Kantarci A (2004). Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 15:165-175.
130. Verrecchia F, Mauviel A (2002). Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118:211-215.
131. Vural F, Ozcan MA, Ozsan GH, Demirkan F, Piskin O, Ates H, et al. (2004). Gingival involvement in a patient with CD56+ chronic myelomonocytic leukemia. Leuk Lymphoma 45:415-418.
132. Wang DZ, Hammond VE, Abud HE, Bertoncello I, McAvoy JW, Bowtell DD (1997). Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development. Genes Dev 11:309-320.
133. Wang W, Fisher EM, Jia Q, Dunn JM, Porfiri E, Downward J, et al. (1995). The Grb2 binding domain of mSos1 is not required for downstream signal transduction. Nat Genet 10:294-300.
134. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG (1996). The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell 87:733-743.
135. Wary KK, Mariotti A, Zurzolo C, Giancotti FG (1998). A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94:625-634.
136. Wright HJ, Chapple IL, Matthews JB (2001). TGF-beta isoforms and TGF-beta receptors in drug-induced and hereditary gingival overgrowth. J Oral Pathol Med 30:281-289.
137. Wynne SE, Aldred MJ, Bartold PM (1995). Hereditary gingival fibromatosis associated with hearing loss and supernumerary teeth-a new syndrome. J Periodontol 66:75-79.
138. Xiao S, Wang X, Qu B, Yang M, Liu G, Bu L, et al. (2000). Refinement of the locus for autosomal dominant hereditary gingival fibromatosis (GINGF) to a 3.8-cM region on 2p21. Genomics 68:247-252.
139. Xiao S, Bu L, Zhu L, Zheng G, Yang M, Qian M, et al. (2001). A new locus for hereditary gingival fibromatosis (GINGF2) maps to 5q13-q22. Genomics 74:180-185.
140. Yamaguchi Y, Hearing VJ, Itami S, Yoshikawa K, Katayama I (2005). Mesenchymal-epithelial interactions in the skin: aiming for site-specific tissue regeneration. J Dermatol Sci 40:1-9.
141. Yates S, Rayner TE (2002). Transcription factor activation in response to cutaneous injury: role of AP-1 in reepithelialization. Wound Repair Regen 10:5-15.
142. Ye X, Shi L, Cheng Y, Peng Q, Huang S, Liu J, et al. (2005). A novel locus for autosomal dominant hereditary gingival fibromatosis, GINGF3, maps to chromosome 2p22.3-p23.3. Clin Genet 68:239-244.
143. Zimmerman CM, Kariapper MS, Mathews LS (1998). Smad proteins physically interact with calmodulin. J Biol Chem 273:677-680.